Literature DB >> 32311816

Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).

Ehtisham Mahmud1, Harold L Dauerman2, Frederick G P Welt3, John C Messenger4, Sunil V Rao5, Cindy Grines6, Amal Mattu7, Ajay J Kirtane8, Rajiv Jauhar9, Perwaiz Meraj10, Ivan C Rokos11, John S Rumsfeld12, Timothy D Henry13.   

Abstract

The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with this novel coronavirus. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating an ST-elevation myocardial infarction (STEMI) presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury, and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on (a) varied clinical presentations; (b) appropriate personal protection equipment (PPE) for health care workers; (c) the roles of the emergency department, emergency medical system, and the cardiac catheterization laboratory (CCL); and (4) regional STEMI systems of care. During the COVID-19 pandemic, primary percutaneous coronary intervention (PCI) remains the standard of care for STEMI patients at PCI-capable hospitals when it can be provided in a timely manner, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI-capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  COVID-19; STEMI; acute myocardial infarction; emergency medical system; fibrinolysis; percutaneous coronary intervention

Mesh:

Year:  2020        PMID: 32311816     DOI: 10.1002/ccd.28946

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  45 in total

Review 1.  2021 Update for the Diagnosis and Management of Acute Coronary Syndromes for the Perioperative Clinician.

Authors:  Katherine J Kunkel; Alejandro Lemor; Shazil Mahmood; Pedro Villablanca; Harish Ramakrishna
Journal:  J Cardiothorac Vasc Anesth       Date:  2021-07-22       Impact factor: 2.894

2.  ST-Elevation Myocardial Infarction With Occluded Culprit Coronary Artery in a Young Patient Recovered From Mild COVID-19: A Case Report.

Authors:  Juan Manuel Muñoz Moreno; Anthony Ramos-Yataco; Erik Villanueva Garcia; Carlos Holguin Palacios; Gina Sánchez Sánchez
Journal:  Cureus       Date:  2022-09-17

Review 3.  Management of ST Elevation Myocardial Infarction (STEMI) in Different Settings.

Authors:  Rod Partow-Navid; Narut Prasitlumkum; Ashish Mukherjee; Padmini Varadarajan; Ramdas G Pai
Journal:  Int J Angiol       Date:  2021-03-24

Review 4.  Cardiovascular manifestations of COVID-19: An evidence-based narrative review.

Authors:  Yash Paul Sharma; Sourabh Agstam; Ashutosh Yadav; Anunay Gupta; Ankur Gupta
Journal:  Indian J Med Res       Date:  2021 Jan & Feb       Impact factor: 2.375

Review 5.  Cardiovascular disease management during the coronavirus disease 2019 pandemic.

Authors:  Wen-Hsien Lee; Ying-Chih Chen; Szu-Chia Chen; Chang-Jen Chen; Po-Chao Hsu; Wei-Chung Tsai; Chun-Yuan Chu; Chee-Siong Lee; Tsung-Hsien Lin; Wen-Chol Voon; Chao-Hung Kuo; Ho-Ming Su
Journal:  Int J Med Sci       Date:  2020-05-29       Impact factor: 3.738

Review 6.  Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic.

Authors:  Sarju Ganatra; Sourbha S Dani; Sachin Shah; Aarti Asnani; Tomas G Neilan; Daniel Lenihan; Bonnie Ky; Ana Barac; Salim S Hayek; Monika Leja; Joerg Herrmann; Paaladinesh Thavendiranathan; Michael Fradley; Vigyan Bang; Katherine Shreyder; Rohan Parikh; Rushin Patel; Amitoj Singh; Simarjeet Brar; Avirup Guha; Dipti Gupta; Paolo Mascari; Richard D Patten; David M Venesy; Anju Nohria; Frederic S Resnic
Journal:  Trends Cardiovasc Med       Date:  2020-05-28       Impact factor: 6.677

7.  Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter.

Authors:  Tarek A Hammad; Melanie Parikh; Nour Tashtish; Cynthia M Lowry; Diane Gorbey; Farshad Forouzandeh; Steven J Filby; William M Wolf; Marco A Costa; Daniel I Simon; Mehdi H Shishehbor
Journal:  Catheter Cardiovasc Interv       Date:  2020-06-01       Impact factor: 2.585

8.  Commentary: Collaboration is key to saving as many lives as possible.

Authors:  Mara B Antonoff
Journal:  J Thorac Cardiovasc Surg       Date:  2020-05-01       Impact factor: 6.439

9.  COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.

Authors:  Rafael Harari; Sripal Bangalore; Ernest Chang; Binita Shah
Journal:  Catheter Cardiovasc Interv       Date:  2020-05-19       Impact factor: 2.585

10.  COVID-19 Pandemic and Volume of Cardiac Catheterization Procedures in Jordan: Impact of Strict Lockdown.

Authors:  Imad A Alhaddad; Ramzi Tabbalat; Ayman Hammoudeh
Journal:  Heart Views       Date:  2021-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.